Bristol-Myers Squibb to collaborate with Chapel Hill data firm
Chapel Hill-based clinical data company Target PharmaSolutions – which secured funding from Rex Health Ventures earlier this year – has landed two new collaborations with Bristol-Myers Squibb.
The collaborations will focus on examining treatment patterns in nonalcoholic steatohepatitis (fatty liver disease) and hepatocellular carcinoma (liver cancer), Targ et PharmaSolutions announced Thursday.
The collaborations also provide Target PharmaSolutions “additional strength as we continue to bring…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Fatty Liver Disease (FLD) | Funding | Health Management | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Pharmaceuticals | Urology & Nephrology